Rare cancers

Theme leader: Carla van Herpen

Despite the rarity of each of the 186 rare cancers (i.e. incidence <6/100,000), they represent in total about 22% of all cancer cases. Examples are head and neck cancer, sarcoma, thyroid cancer, neuroendocrine cancer, brain tumors, lymphoma, and pediatric cancer. They pose particular challenges due to their low frequency, including (i) late or incorrect diagnosis; (ii) lack of access to appropriate therapies and clinical expertise; (iii) a very limited number of clinical trials due to the small number of patients; (iv) lack of interest in the development of new therapies due to limitations in the market; (v) few available registries and tissue banks. Our mission is to improve diagnosis and prognosis for this patient group in an (inter)national collaborative setting.

 

Theme news

Next theme events

Mar 24 - Mar 24
Graduation: Ilse van Engen-van GrunsvenGenetic alterations in rare subtypes of melanocytic tumors; towards improved diagnosis and therapy
Mar 30 - Mar 30
Radboud Research Rounds Plus: Prof. Reinhard JahnRadboud Research Rounds Plus: Prof. Reinhard Jahn
Apr 20 - Apr 21
RIMLS PhD retreat 2017RIMLS PhD retreat 2017

Related assistant / associate / full professors

Blijlevens, Nicole
Blijlevens, NicoleThe research focus on personalized supportive care in hematology patients is targeted to stem cell transplant recipients. read more >>
Bussink, Jan
Bussink, Janread more >>
Bram_van_Ginneken.jpg
van Ginneken, Bramread more >>
Graaf Van Der, Winette
van der Graaf, WinetteBringing preclinical findings from the lab to the clinic and vice versaread more >>
Herpen, Carla van
van Herpen, CarlaMore than 4 million people in the European Union are affected by rare cancers. Despite the rarity of each of the 186 rare cancers, they represent in total about 22% of all cancer cases. This is more than any single common cancer. Rare cancers are identified as those with an incidence of less than 6 per 100,000 persons per year. Examples of rare cancer are head and neck cancer, sarcoma, thyroid cancer, neuroendocrine cancer, brain tumors, lymphoma, and pediatric cancer. Unfortunately, the average outcome for patients with a rare cancer is inferior to those with more common cancers. Rare cancers pose particular challenges due to their low frequency, including: 1 Late or incorrect diagnosis 2 Lack of access to appropriate therapies and clinical expertise 3 A very limited number of clinical trials due to the small number of patients 4 Lack of interest in the development of new therapies due to limitations in the market 5 Few available registries and tissue banks Our mission is to improve diagnosis and prognosis, to perform (personalized) clinical studies and translational research - from bench to bedside – in patients with rare cancer. This will be performed in relationship with patients advocacy groups, if applicable. Given the rarity of the tumors collaboration with (inter)national centers and partners is vital for the success of this theme.read more >>
Kaanders , Hans
Kaanders, Hansread more >>
Marres , Henri
Marres, Henriread more >>
Merkx , Thijs
Merkx, Thijsread more >>
Oyen , Wim
Oyen, Wimread more >>
Stevens - Kroef, Marian
Stevens-Kroef, Marianread more >>
Wesseling, Pieter
Wesseling, PieterMolecular and cellular dissection of tumour micro-environment interactions in brain tumours.read more >>

Involved departments

Publications highlights